UCLA Hematologyoncology — Los Angeles, California

UCLA Hematologyoncology is a clinical research site located in Los Angeles, California, United States 90095-3075.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematologyoncology has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Mature B-Cell Malignancies.

Sponsors: BeiGene, BeOne Medicines.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematologyoncology?

UCLA Hematologyoncology has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematologyoncology conducted?

UCLA Hematologyoncology has 3 clinical trials on record, with 2 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Mature B-Cell Malignancies.

Is UCLA Hematologyoncology accredited by Crixeo Health?

UCLA Hematologyoncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematologyoncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.